Jazz Pharmaceuticals (JAZZ) on Watch Following Tweet by Shkreli

September 1, 2016 3:00 PM EDT

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Jazz Pharmaceuticals (NASDAQ: JAZZ) shares were in focus Thursday following a positive mentioned by Martin Shkreli. He thinks shares are worth double the current stock price.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Trader Talk

Add Your Comment